Direct Answer

Idexx Laboratories reports revenue across 3 business segments in its fiscal 2025 Form 10-K. Companion Animal Group is the largest, with $4.0 billion of revenue (92% of the total), followed by Water at $201 million (5%).

How Does Idexx Laboratories Make Money?

Companion Animal Group supplies 92% of revenue, so Idexx Laboratories's results move mostly with that one business; the others matter more for diversification than for the headline number. Between fiscal 2024 and 2025, Companion Animal Group grew fastest (+10.6%) and Livestock and Poultry Diagnostics slowest (+8.0%), so the revenue mix tilts toward Companion Animal Group while that gap lasts.

SegmentFY2025 revenueFY2024 revenueShare of revenueChange
Companion Animal Group$4.0 billion$3.6 billion91.9%10.6%
Water$201 million$185 million4.7%8.7%
Livestock and Poultry Diagnostics$132 million$122 million3.1%8.0%
Bar chart of Idexx Laboratories revenue by segment for fiscal 2025: Companion Animal Group 91.9%, Water 4.7%, Livestock and Poultry Diagnostics 3.1%.
Idexx Laboratories revenue by segment as a share of total revenue, from the table above. The largest is highlighted. Select the chart to open it full size.

What Does Idexx Laboratories Sell?

Idexx Laboratories also breaks revenue down by product and service line, which shows what customers pay for rather than how management organizes the business.

Product or serviceFY2025 revenueFY2024 revenueShare of revenueChange
Product$2.5 billion$2.2 billion59.0%12.9%
Service$1.8 billion$1.6 billion41.0%7.0%

What the Segment Figures Do Not Show

The rows above add up to 100% of Idexx Laboratories's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.

Where These Numbers Come From

Every figure on this page is a value Idexx Laboratories reported in the segment note and revenue disclosures of its Form 10-K filed February 20, 2026 (accession 0000874716-26-000038), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.

Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.

Frequently Asked Questions

What are Idexx Laboratories's business segments?

In its fiscal 2025 Form 10-K, Idexx Laboratories reports revenue for Companion Animal Group, Water and Livestock and Poultry Diagnostics.

Which part of Idexx Laboratories brings in the most revenue?

Companion Animal Group, with $4.0 billion of revenue in fiscal 2025, or 92% of the total.

Where does Idexx Laboratories report its segment results?

In the segment note to the financial statements in its Form 10-K, most recently filed February 20, 2026, alongside management's discussion of each segment's results.

References

Related Pages